Plant Comparison
Andrographis vs Japanese knotweed
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Andrographis and Japanese knotweed: they share 4 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Andrographis | Japanese knotweed | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 2/10 | Stronger for Andrographis |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 5/10 | 7/10 | Stronger for Japanese knotweed |
| Skin irritation | 5/10 | 1/10 | Stronger for Andrographis |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Considered the principal bioactive constituents, responsible for much of the antioxidant, anti-inflammatory and cardioprotective activity attributed to this root.
Emodin has laxative and anti-inflammatory activity at typical concentrations but can cause gastrointestinal upset at high doses.
Pharmacological Actions
Andrographolide, the principal diterpene lactone of Andrographis paniculata, suppresses proliferation and induces apoptosis across breast, lung, colon, cervical, hepatic and haematological cancers via NF-kappaB and PI3K/Akt inhibition (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Andrographolide (from Andrographis paniculata) acts as a chemopreventive and antitumour agent against breast, lung, colorectal, cervical, prostate and hepatocellular cancers and leukaemia, inducing apoptosis and inhibiting NF-kappaB and PI3K/AKT signalling (preclinical).
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
Immunostimulant / immune support
Symptomatic relief of the common cold and acute upper respiratory tract infection (reduces symptom severity and duration)
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Avoid in pregnancy and when trying to conceive: high doses have shown reproductive toxicity in animals and the herb has a traditional reputation as an abortifacient.
High doses have caused nephrotoxicity and reproductive toxicity in studies; use standardized products at recommended doses and avoid prolonged high-dose use.
Japanese knotweed root contains resveratrol and emodin; high doses of emodin may cause GI discomfort and have laxative effects. Not recommended during pregnancy (emodin has potential teratogenic effects in animal studies). May interact with anticoagulants and antiplatelet medications. Quality control of commercial preparations is important as invasive weed extracts vary significantly.
Duke (2002) rates Japanese knotweed (listed as Hu-Zhang, Fallopia japonica) as +++ and highlights its rich content of resveratrol and emodin. Experimental evidence (score 1) supports COX-2 inhibitory, antioxidant, anti-inflammatory, hepatoprotective, and lipid-lowering activities — largely attributed to resveratrol. Duke notes its use in traditional Chinese medicine for fractures, burns, abscesses, and gynecological conditions. No significant clinical trials were available at time of publication, but resveratrol's biological activity is well-documented in vitro (Duke, 2002).
External Ids
Botanical Description
Erect, branching annual herb with a slender, quadrangular (square-sectioned), dark green stem. The leaves are opposite, lance-shaped and glabrous, with a short stalk. Small, two-lipped, white flowers with purple-pink markings are borne in loose, spreading axillary and terminal racemes. The whole plant, and especially the leaves, is intensely and characteristically bitter.[11]
Vigorous, invasive rhizomatous perennial (Polygonaceae) with hollow, bamboo-like, jointed stems 1-3 m tall (occasionally taller), speckled reddish-purple. Leaves are broad, heart- to shovel-shaped with a flat base. Abundant sprays of small, creamy-white flowers appear in late summer, followed by small winged fruit.[6]
Habitat
Native to India and Sri Lanka and widely distributed through South and Southeast Asia, growing wild in plains, hillsides, roadsides and cultivated fields; also grown commercially as a medicinal crop.[11]
Native to East Asia (Japan, China, Korea), now a notorious invasive species across Europe and North America, growing in disturbed ground, riverbanks, roadsides and waste land, spreading aggressively via an extensive rhizome network.[6]
Harvesting
The aerial parts (leaves and tender stems) are cut just before or at the onset of flowering, when andrographolide content is typically highest, and dried in shade to preserve the bitter diterpenoid lactones.[11]
The rhizome/root, the main medicinal part, is dug in autumn or winter when resveratrol content is highest; young spring shoots (stems) are also edible and used. Strict containment is required when harvesting, given the plant's severe invasiveness.[6]
Traditional Uses
Andrographis, the 'king of bitters', is a cornerstone bitter tonic of Ayurvedic and traditional Chinese medicine (Chuan xin lian), used for fevers, colds, sore throat, infections and liver complaints. This traditional reputation for treating the common cold and upper respiratory infections is now supported by clinical trials of standardised extracts.[10, 12]
Known as Hu Zhang in Traditional Chinese Medicine, Japanese knotweed root has a centuries-old use for inflammation, infections, jaundice and menstrual complaints. Modern interest centres on its resveratrol and emodin content, now studied (as Polygonum cuspidatum extract) for antioxidant, anti-inflammatory, cardioprotective and hepatoprotective activity, and more recently for supportive use in acute respiratory infections.[2, 3, 6]
Preparations
Dried aerial parts infused or lightly decocted in hot water as a very bitter traditional fever and cold remedy.
Dosage
Clinical trials for upper respiratory infection commonly use extracts standardised to around 60-120 mg andrographolide daily, in divided doses, for up to 5-7 days. Educational reference only, not a prescription.
The WHO monograph on Herba Andrographidis gives, by indication - for the common cold, 1.5-3.0 g of the powdered crude drug three times daily, after meals and at bedtime; for pyrexia, a decoction from 3 g of the crude drug twice daily; for diarrhoea, a decoction from 3-9 g as a single dose as needed, or two 500 mg tablets four times daily. Note that the EMA HMPC assessed this herb and issued a public statement rather than a monograph, so there is no EU posology. Educational reference only, not a prescription.
Duke (2002) and general phytotherapy guidance treat this as an experimentally supported herb without a single agreed clinical dose; commercial resveratrol-standardised extracts should be dosed per product labelling. Educational reference only, not a prescription; avoid in pregnancy.
References
Lookalikes Review
References & Sources
- Okonogi, R. and others (2023) 'Efficacy of Andrographis paniculata spray in acute pharyngitis: A randomized controlled trial', Drug Discoveries & Therapeutics, 17(5), pp. 315-321. doi:10.5582/ddt.2023.01053 Randomized trial
https://doi.org/10.5582/ddt.2023.01053 - Hossain, S., Urbi, Z., Karuniawati, H., Mohiuddin, R.B. and others (2018) 'Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide', Critical Reviews in Food Science and Nutrition, 61(10), pp. 1635-1652. doi:10.1080/10408398.2018.1501657 Meta-analysis / review
https://doi.org/10.1080/10408398.2018.1501657 - Worakunphanich, W. and others (2021) 'Andrographis paniculata Formulations: Impact on Diterpene Lactone Oral Bioavailability', European Journal of Drug Metabolism and Pharmacokinetics, 46(5), pp. 565-581. doi:10.1007/s13318-021-00736-7 Meta-analysis / review
https://doi.org/10.1007/s13318-021-00736-7 - Worakunphanich, W., Thavorncharoensap, M., Youngkong, S., Thakkinstian, A. and Chaikledkaew, U (2021) 'Safety of Andrographis paniculata: A systematic review and meta-analysis', Pharmacoepidemiology and Drug Safety, 30(6), pp. 727-739. doi:10.1002/pds.5190 Meta-analysis / review
https://doi.org/10.1002/pds.5190 - Kumar, S., Singh, B. and Bajpai, V (2021) 'Andrographis paniculata (Burm.f.) Nees and its major constituent andrographolide as potential antiviral agents', Journal of Ethnopharmacology, 274, pp. 113954. doi:10.1016/j.jep.2021.113954 Meta-analysis / review
https://doi.org/10.1016/j.jep.2021.113954 - Barbosa, F.L. and others (2021) 'Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy', Life, 11(4), pp. 348. doi:10.3390/life11040348 Meta-analysis / review
https://doi.org/10.3390/life11040348 - Singh, P. and others (2022) 'Andrographis paniculata mitigates first-line anti-tubercular drugs-induced nephrotoxicity in Wistar rats', Biomarkers, 27(4), pp. 385-394. doi:10.1080/1354750X.2022.2043444 Preclinical
https://doi.org/10.1080/1354750X.2022.2043444 - Coon, J.T. and Ernst, E (2004) 'Andrographis paniculata in the symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials', Journal of Clinical Pharmacy and Therapeutics, 29(1), pp. 37-45. doi:10.1046/j.1365-2710.2003.00534.x Meta-analysis / review
https://doi.org/10.1046/j.1365-2710.2003.00534.x - Rondee, N. and others (2023) 'The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases', Nutrients, 15(15), pp. 3428. doi:10.3390/nu15153428 Meta-analysis / review
https://doi.org/10.3390/nu15153428 - Zeng, B., Wei, A., Zhou, Q., Yuan, M., Lei, K., Liu, Y., Song, J., Guo, L. and Ye, Q (2021) 'Andrographolide: A review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches', Phytotherapy Research. doi:10.1002/ptr.7324 Randomized trial
https://doi.org/10.1002/ptr.7324 - Gonde, D.P., Bhole, B.K. and Kakad, K.S (2023) 'Andrographolide, diterpenoid constituent of Andrographis paniculata: Review on botany, phytochemistry, molecular docking analysis, and pharmacology', Annales Pharmaceutiques Francaises. doi:10.1016/j.pharma.2023.10.001 Preclinical
https://doi.org/10.1016/j.pharma.2023.10.001 - Hu, X.Y., Wu, R.H., Logue, M., Blondel, C., Lai, L.Y.W., Stuart, B., Flower, A., Fei, Y.T., Moore, M., Shepherd, J., Liu, J.P. and Lewith, G (2017) 'Andrographis paniculata (Chuan Xin Lian) for symptomatic relief of acute respiratory tract infections in adults and children: A systematic review and meta-analysis', PLoS ONE. doi:10.1371/journal.pone.0181780 Meta-analysis / review
https://doi.org/10.1371/journal.pone.0181780 - World Health Organization (2002) 'Herba Andrographidis'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Tundis, R. and Patra, J.K. and Bonesi, M. and Das, S. and Nath, R. and Das Talukdar, A. and Das, G. and Loizzo, M.R (2023) 'Anti-Cancer Agent: The Labdane Diterpenoid-Andrographolide', Plants, 12(10), pp. 1969. doi:10.3390/plants12101969 Preclinical
https://doi.org/10.3390/plants12101969 - Mishra, S.K. and Tripathi, S. and Shukla, A. and Oh, S.H. and Kim, H.M (2015) 'Andrographolide and analogues in cancer prevention', Frontiers in Bioscience (Elite Edition), 7(2), pp. 255-266. doi:10.2741/E732 Preclinical
https://doi.org/10.2741/E732 - Paul, S. and Roy, D. and Pati, S. and Sa, G (2021) 'The Adroitness of Andrographolide as a Natural Weapon Against Colorectal Cancer', Frontiers in Pharmacology, 12, pp. 731492. doi:10.3389/fphar.2021.731492 Preclinical
https://doi.org/10.3389/fphar.2021.731492 - Memorial Sloan Kettering Cancer Center (n.d.) 'Andrographis (About Herbs)'. Available at: https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis Traditional / reference
https://www.mskcc.org/cancer-care/integrative-medicine/herbs/andrographis
- Dong, X., Fu, J., Yin, X., Cao, S. and others (2016) 'Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics', Phytotherapy Research, 30(8), pp. 1207-1218. doi:10.1002/ptr.5631 Traditional / reference
https://doi.org/10.1002/ptr.5631 - Wang, S., Yang, Y., Sun, L., Qiao, G. and others (2022) 'Reynoutria japonica Houtt for Acute Respiratory Tract Infections in Adults and Children: A Systematic Review', Frontiers in Pharmacology, 13, pp. 787032. doi:10.3389/fphar.2022.787032 Meta-analysis / review
https://doi.org/10.3389/fphar.2022.787032 - Ke, Y., Zhan, L., Lu, T., Zhou, C. and others (2023) 'Advances for pharmacological activities of Polygonum cuspidatum (Reynoutria japonica) - A review', Pharmaceutical Biology, 61(1), pp. 177-188. doi:10.1080/13880209.2022.2158349 Traditional / reference
https://doi.org/10.1080/13880209.2022.2158349 - Zhang, Q., Zhao, Y., Zhang, M., Zhang, Y. and others (2021) 'Bioactive amides from Reynoutria japonica', Journal of Asian Natural Products Research, 23(3), pp. 228-234. doi:10.1080/10286020.2021.1873298 Preclinical
https://doi.org/10.1080/10286020.2021.1873298 - Lai, Y., Zhou, C., Huang, P., Dong, Z. and others (2024) 'Polygonum cuspidatum polysaccharide: A review of its extraction and purification, structure analysis, and biological activity', Journal of Ethnopharmacology, 331, pp. 118079. doi:10.1016/j.jep.2024.118079 Traditional / reference
https://doi.org/10.1016/j.jep.2024.118079 - Peng, W., Qin, R., Li, X. and Zhou, H (2013) 'Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb. et Zucc.: a review', Journal of Ethnopharmacology, 148(3), pp. 729-745. doi:10.1016/j.jep.2013.05.007 Traditional / reference
https://doi.org/10.1016/j.jep.2013.05.007 - Wang, X., Liang, L., Yan, J., Li, Z. and others (2023) 'Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. herb pair suppresses breast cancer liver metastasis by targeting ECM1-mediated cholesterol biosynthesis pathway', Phytomedicine, 116, pp. 154896. doi:10.1016/j.phymed.2023.154896 Preclinical
https://doi.org/10.1016/j.phymed.2023.154896 - Jiang, Y., Liu, Y., Zhang, X. and others (2020) 'New phenolic glycosides from Reynoutria japonica', Journal of Asian Natural Products Research, 22(1), pp. 17-23. doi:10.1080/10286020.2019.1646730 Preclinical
https://doi.org/10.1080/10286020.2019.1646730 - Liu, Y., Wang, J., Li, Q. and others (2024) 'The Possibility of Polygonum cuspidatum against Osteoarthritis based on Network Pharmacology', Current Computer-Aided Drug Design, 20(2), pp. 121-133. doi:10.2174/1573409919666230403114131 Preclinical
https://doi.org/10.2174/1573409919666230403114131 - Espinosa-Andrews, H., Morales-Hernandez, N., Garcia-Marquez, E. and others (2025) 'Physicochemical and rheological characteristics of commercial Greek-style yogurt enriched with Polygonum cuspidatum roots or the P. cuspidatum beta-cyclodextrin inclusion complex', Food Research International, 203, pp. 115854. doi:10.1016/j.foodres.2025.115854 Preclinical
https://doi.org/10.1016/j.foodres.2025.115854 - Burns, J., Yokota, T., Ashihara, H., Lean, M.E.J. and Crozier, A (2002) 'Plant foods and herbal sources of resveratrol', 50(11), pp. 3337--3340. doi:10.1021/jf0112973 Traditional / reference
https://doi.org/10.1021/jf0112973 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2007) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.